Skip to main content
SpringerLink
Log in

Oral l-Arginine Supplementation and Glucose Metabolism and Vascular Function

  • Chapter
  • First Online:
L-Arginine in Clinical Nutrition

Part of the book series: Nutrition and Health ((NH))

Abstract

It is well known that metabolic syndrome is a cluster of metabolic abnormalities, which includes impaired glucose regulation, hypertension, dyslipidaemia, obesity, and increased cardiovascular disease risk (Alberti et al., Circulation 120:1640–1645, 2009). Metabolic syndrome affects one in five people, and prevalence increases with age; some studies estimate the prevalence in the USA to be nearly 25 % of the population (Park et al., Arch Intern Med 163:427–436, 2003).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.

    Article  CAS  PubMed  Google Scholar 

  2. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Arch Intern Med. 2003;163:427–36.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Piatti P, Fragasso G, Monti LD, Caumo A, Van Phan C, Valsecchi G, Costa S, Fochesato E, Pozza G, Pontiroli AE, Chierchia S. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol. 1999;34:1452–60.

    Article  CAS  PubMed  Google Scholar 

  4. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension and cardiovascular disease: which role for oxidative stress. Metabolism. 1995;44:363–8.

    Article  CAS  PubMed  Google Scholar 

  5. Paolisso G, Tagliamonte MR, Marfella R, Verrazzo G, D’Onofrio F, Giugliano D. l-arginine but not D-arginine stimulates insulin-mediated glucose uptake. Metabolism. 1997;46:1068–73.

    Article  CAS  PubMed  Google Scholar 

  6. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990;30:535–60.

    Article  CAS  PubMed  Google Scholar 

  7. Monti L, Valsecchi G, Costa S, Sandoli EP, Phan CV, Pontiroli AE, Pozza G, Piatti PM. Effects of endothelin-1 and nitric oxide on glucokinase activity in isolated rat hepatocytes. Metabolism. 2000;49:73–80.

    Article  CAS  PubMed  Google Scholar 

  8. Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE, Carroll RJ, Meininger CJ, Wu G. Dietary l-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr. 2005;135:714–21.

    CAS  PubMed  Google Scholar 

  9. Monti LD, Galluccio E, Lucotti P, Setola E, Costa S, Fontana B, Oldani M, Merante D, Di Blasi P, Bosi E, Piatti PM. Beneficial role of l-arginine in cardiac matrix remodelling in insulin resistant rats. Eur J Clin Invest. 2008;38:849–56.

    Article  CAS  PubMed  Google Scholar 

  10. McConell GK, Huynh NN, Lee-Young RS, Canny BJ, Wadley GD. l-arginine infusion increases glucose clearance during prolonged exercise in humans. Am J Physiol Endocrinol Metab. 2006;290:E60–6.

    Article  CAS  PubMed  Google Scholar 

  11. Wascher TC, Graier WF, Dittrich P, Hussain MA, Bahadori B, Waliner S, Topiak H. Effects of low-dose l-arginine on insulin mediated vasodilation and insulin sensitivity. Eur J Clin Invest. 1997;27:690–5.

    Article  CAS  PubMed  Google Scholar 

  12. Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti KG. Long-term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care. 2001;24:875–80.

    Article  CAS  PubMed  Google Scholar 

  13. Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P. Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2006;291:E906–12.

    Article  CAS  PubMed  Google Scholar 

  14. Lucotti P, Monti L, Setola E, La Canna G, Castiglioni A, Rossodivita A, Pala MG, Formica F, Paolini G, Catapano AL, Bosi E, Alfieri O, Piatti P. Oral l-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism. 2009;58:1270–6.

    Article  CAS  PubMed  Google Scholar 

  15. Monti LD, Setola E, Lucotti PC, Marrocco-Trischitta MM, Comola M, Galluccio E, Poggi A, Mammì S, Catapano AL, Comi G, Chiesa R, Bosi E, Piatti PM. Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2012;14:893–900.

    Article  CAS  PubMed  Google Scholar 

  16. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. l-arginine augments endothelium-dependent vasodilation in cholesterol-feed rabbits. Circ Res. 1990;67:1301–8.

    Article  CAS  PubMed  Google Scholar 

  17. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of l-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Boger RH, Bode-Boger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC. Supplementation of hypercholesterolemic rabbits with l-arginine reduces vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995;141:31–43.

    Article  Google Scholar 

  19. Dhawan V, Handu SS, Nain CK, Ganguly NK. Chronic l-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys. Mol Cell Biochem. 2005;269:1–11.

    Article  CAS  PubMed  Google Scholar 

  20. Hayashi T, Juliet PA, Matsui-Hirai H, Miyazaki A, Fukatsu A, Funami J, Iguchi A, Ignarro LJ. L-citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci USA. 2005;20:13681–6.

    Article  Google Scholar 

  21. Willot M, Gray L, Gibson C, Murphy S, Bath PMW. A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide. 2005;12:141–9.

    Article  Google Scholar 

  22. Boger RH, Bode-Boger SM. The clinical pharmacology of l-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79–99.

    Article  CAS  PubMed  Google Scholar 

  23. Dong JY, Qin LQ, Zhang Z, Zhao Y, Wang J, Arigoni F, Zhang W. Effect of oral l-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials. Am Heart J. 2011;162(6):959–65.

    Article  CAS  PubMed  Google Scholar 

  24. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. l-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A. Effects of l-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation. 1996;94:130–4.

    Article  CAS  PubMed  Google Scholar 

  26. Piatti P, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, Paroni R, Galluccio E, Pozza G, Chierchia S, Margonato A. Acute intravenous l-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation. 2003;107:429–36.

    Article  CAS  PubMed  Google Scholar 

  27. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral l-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol. 1995;26:1054–61.

    Article  CAS  PubMed  Google Scholar 

  28. Bode-Boger SM, Muke J, Surdacki A, Brabant G, Boger RH, Frolich JC. Oral l-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med. 2003;8:77–81.

    Article  PubMed  Google Scholar 

  29. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredle R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE. Oral l-arginine improves endothelium-dependent vasodilation of hypercholesterolemic young adults. J Clin Invest. 1996;97:1989–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, Schuler G. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral l-arginine supplementation. J Am Coll Cardiol. 2000;35:706–13.

    Article  CAS  PubMed  Google Scholar 

  31. Palloshi A, Fragasso G, Piatti P, Monti LD, Setola E, Valsecchi G, Galluccio E, Chierchia SL, Margonato A. Effect of oral l-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol. 2004;93:933–5.

    Article  CAS  PubMed  Google Scholar 

  32. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572–5.

    Article  CAS  PubMed  Google Scholar 

  33. Abbasi F, Asagami T, Cooke JP, Lamendola C, McLaughin T, Reaven GM, Stuehlinger M, Tsao PS. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol. 2001;88:1201–3.

    Article  CAS  PubMed  Google Scholar 

  34. Closs EI, Basha FZ, Habermeier A, Forstermann U. Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide. 1997;1:65–73.

    Article  CAS  PubMed  Google Scholar 

  35. Schlaich MP, Parnell MM, Ahlers BA, Finch S, Marshall T, Zhang WZ, Kaye DM. Impaired l-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation. 2004;110:3680–6.

    Article  CAS  PubMed  Google Scholar 

  36. Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral l-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis. 1997;129:261–9.

    Article  CAS  PubMed  Google Scholar 

  37. Cerumuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral l-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol. 1997;80:331–3.

    Article  Google Scholar 

  38. Fukumoto Y, Urabe Y, Kubo T, Kaku T, Egashira K, Shimokawa H, Takeshita A. Augmented vasodilator response to l-arginine after coronary angioplasty may attenuate restenosis. Heart Vessels. 2002;16:171–4.

    Article  PubMed  Google Scholar 

  39. Shiraki T, Takamura T, Kajiyama A, Oka T, Saito D. Effect of short-term administration of high dose l-arginine on restenosis after percutaneous transluminal coronary angioplasty. J Cardiol. 2004;44:13–20.

    PubMed  Google Scholar 

  40. Lerman A, Burnett Jr JC, Higano ST, McKinley LJ, Holmes Jr DR. Long term l-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation. 1998;97:2123–8.

    Article  CAS  PubMed  Google Scholar 

  41. Oomen CM, van Erk MJ, Feskens EJ, Kok FJ, Kromhout D. Arginine intake and risk of coronary heart disease mortality in elderly men. Arterioscler Thromb Vasc Biol. 2000;20:2134–9.

    Article  CAS  PubMed  Google Scholar 

  42. Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waclawiw MA, Panza JA, Cannon 3rd RO. Oral l-arginine in patients with coronary artery disease on medical management. Circulation. 2000;101:2160–4.

    Article  CAS  PubMed  Google Scholar 

  43. Tsai CH, Pan TL, Lee YS, Tai YK, Liu TZ. Evidence that high-dose l-arginine may inappropriate for use by diabetic patients as prophylactic blocker of methylglyoxal glycation. J Biomed Sci. 2004;11:692–6.

    CAS  PubMed  Google Scholar 

  44. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes formation and activity of peroxynitrite. Lab Invest. 1996;75:77–85.

    CAS  PubMed  Google Scholar 

  45. Maxwell AJ, Anderson BE, Cooke JP. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBarReg. Vasc Med. 2000;5(1):11–9.

    CAS  PubMed  Google Scholar 

  46. Abdelhamed AI, Reis SE, Sane DC, Brosnihan KB, Preli RB, Herrington DM. No effect of an l-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia. Am Heart J. 2003;145(3):E15.

    Article  PubMed  Google Scholar 

  47. Monti LD, Casiraghi MC, Setola E, Galluccio E, Pagani MA, Quaglia L, Bosi E, Piatti P. l-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome. Metabolism. 2013;62(2):255–64.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardio-Diabetes and Core Lab and Cardio-Metabolism and Clinical Trials Unit, IRCCS San Raffaele Scientific Institute, Diabetes Research Institute, Via Olgettina 60, 20132, Milan, Italy

    Lucilla D. Monti MD, Elena Galluccio PhD, Barbara Fontana, Emanuele Bosi & Piermarco Piatti MD

Authors
  1. Lucilla D. Monti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Galluccio PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara Fontana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emanuele Bosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Piermarco Piatti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lucilla D. Monti MD .

Editor information

Editors and Affiliations

  1. Faculty of Science & Technology Department of Biomedical Sciences, University of Westminster, London, United Kingdom

    Vinood B. Patel

  2. Department Nutrition and Dietetics Nutritional Sciences Division School of Biomedical & Health Sciences, King’s College London, London, United Kingdom

    Victor R. Preedy

  3. Nutritional Sciences Research Division Faculty of Life Science and Medicine, King’s College London, London, United Kingdom

    Rajkumar Rajendram

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Monti, L.D., Galluccio, E., Fontana, B., Bosi, E., Piatti, P. (2017). Oral l-Arginine Supplementation and Glucose Metabolism and Vascular Function. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26009-9_32

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-26007-5

  • Online ISBN: 978-3-319-26009-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation